Physician profile
Amy E Croft
NPI 1780786640
$525.87
in general payments reported to CMS, 2019-2025
11 companies · $19.21 in 2025
The $19.21 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.08 · 2022: $203 · 2023: $173 · 2024: $57.97 · 2025: $19.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $216.94 | 2022-2023 | Sonopet Iq |
| Boston Scientific Corporation | $68.67 | 2022 | |
| Alexion Pharmaceuticals, INC. | $51.53 | 2022 | |
| Depuy Synthes Sales INC. | $45.32 | 2022-2025 | Trialtis |
| Baxter Healthcare | $35.21 | 2021 | |
| Bioventus LLC | $34.09 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Astrazeneca Pharmaceuticals Lp | $23.88 | 2024 | Andexxa |
| Microvention, INC. | $14.45 | 2021 | |
| Abbott Laboratories | $13.36 | 2023 | Infinity |
| Medtronic, INC. | $11.68 | 2021 | |
| Irras USA, INC. | $10.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Croft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.